Rxi pharma stock price

RXI Pharma (RXII) Prices Common Stock, Warrant Units at $0.90

Stock analysis for Biosyent Inc (RX:Venture) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Biotech & Pharma-0.42%. Sponsored By. Ratings | Benzinga Jan 01, 2010 · RXI Pharma (NASDAQ: RXII) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. RXi Pharmaceuticals (RXII) Stock: Tanking On Offering ... Oct 01, 2018 · RXi Pharmaceuticals the company said that it has priced an underwritten public offering of 21,428,572 units at a price of $0.70 per unit. Zealand Pharma (ZEAL) Stock: Soaring On Asset Sale Biotech Stock Mailbag: Avanir Pharma - TheStreet Apr 01, 2011 · Biotech Stock Mailbag: Avanir Pharma. Total value of the deal: $7.2 million, based on RXi's stock price when the deal was announced. So, $7.2 million for a phase III breast cancer drug?

RXi Pharma raises $15M in equity offering. Stock Markets Oct 03, 2018 04:35PM ET. Saved. and so prices may not be accurate and may differ from the actual market price, meaning prices are

RXII - Rxi Pharmaceuticals Stock Profile - Barchart.com Company profile for Rxi Pharmaceuticals (RXII) including business summary, key statistics, ratios, sector. RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing therapies based on its RNAi platform. A stock's Profile page contains general information about the stock, such as PHIO: Phio Pharma Stock Price - Investing.com Get today's Phio Pharmaceuticals Corp stock price and latest PHIO news as well as Phio Pharma real-time stock quotes, technical analysis, full financials and more. Galena Biopharma - Wikipedia Galena Biopharma (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, and in 2015 moved to San Ramon, California. Mark Schwartz was the company's president and chief executive officer.

Biotech Stock Mailbag: Avanir Pharma - TheStreet

RXi Pharma VERSATILE TECHNOLOGY PLATFORM. Proprietary self-delivering RNAi platform with broad applicability towards immune effector cells and tumor microenvironment

Benzinga | Stock Market Quotes, Business News, Financial ...

Find the latest Phio Pharmaceuticals Corp. (PHIO) stock quote, history, news and other vital information to help you with your stock trading and investing. Phio Pharmaceuticals Corp (PHIO) Stock Message Board ... Mar 31, 2020 · RXi Pharmaceuticals Announces Pharmacokinetic Results of its Single Dose Phase 1 Study with RXI-109 in Healthy Volunteers - November 15, 2012 RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2012 - November 14, 2012 RXi Pharmaceuticals to Present at 12th Annual Biotech Symposium - October 16, 2012 RXi Pharmaceuticals - Stock Price History | PHIO | MacroTrends Historical daily share price chart and data for RXi Pharmaceuticals since 2020 adjusted for splits. The latest closing stock price for RXi Pharmaceuticals as of April 03, 2020 is 1.69.. The all-time high RXi Pharmaceuticals stock closing price was 990.99 on March 14, 2013.; The RXi Pharmaceuticals 52-week high stock price is 10.85, which is 542% above the current share price. RXI Pharmaceuticals Corporation Stock Price - RXII RXI Pharmaceuticals Corporation stock quote and RXII charts. Latest stock price today and the US's most active stock market forums. RXI Pharmaceuticals Corporation (RXII) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

RXI Pharma (RXII) Prices Common Stock, Warrant Units at $0.90 The conversion price of the preferred stock and the exercise price of the warrants are fixed and do not contain any variable

Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer. The company's lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin and eye. RXi Pharma VERSATILE TECHNOLOGY PLATFORM. Proprietary self-delivering RNAi platform with broad applicability towards immune effector cells and tumor microenvironment Career Opportunities | RXi Pharmaceuticals RXi Pharmaceuticals actively recruits individuals with an entrepreneurial spirit and a drive for excellence. To be considered for any of our current openings or future opportunities, please send a cover letter indicating the position of interest along with your resume to our Human Resources Department at hr@rxipharma.com

Stock Quote & Chart - RXi Pharmaceuticals The Investor Relations website contains information about Phio Pharmaceuticals's business for stockholders, potential investors, and financial analysts. RXII Stock Quote - Phio Pharmaceuticals Corp - Bloomberg ... Stock analysis for Phio Pharmaceuticals Corp (RXII) including stock price, stock chart, company news, key statistics, fundamentals and company profile. - RXII - Stock Price Today - Zacks View %COMPANY_NAME% RXII investment & stock information. Get the latest %COMPANY_NAME% RXII detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.